[ad_1]
XBiotech Micro Business Headset (XBIT) + 23.8%) is up almost 5 times the volume, trying to reverse a nearly 50% sale since last week.
This morning, the company announced that the famous cardiologist Peter Libby had joined his scientific council. It will help develop its research programs and clinical programs, including assessing the ability of bermekimab to reduce the risk of heart attack or stroke.
Dr. Libby's group has discovered a mechanism behind heart attacks and strokes that may involve inflammation.
[ad_2]
Source link
